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Chapter
Case Study 5: Analysis of Process
Capability and Quality of Monoclonal
Antibody Production in Bioreactor
lIIui:Jrot'<l1I Md. Mo"" lM"ai/ Ahdul Kurim. Puridull li.wif
1. Introduction
Sin.:c the advent ol"mooo<;k,nui anli"o,hc~ (MAlls) from hybridom3
cells in 1975. hybri<.lurnu [.:chrlulngy has had a major imp<l<:1 011 Ih,'
sciemitic and rcsc:lrch world. The dcman<l tor MAils has onncas,'<J
CQn"idcrahly in recenl years. MAbs art: being osc<l in in-vitro
diugnoslie'. ;mIllUI1O;llTini,y chrommogmpby. in vivo imaging and
immullolh,>rapy (Jachon. 1\)<)9: Fr"shllcy. 20(0). While Ihe dcnmm.l
for MAbs will remain primarily sl"blc in other areas. il is projected
Ihm hUlll"1l therapy (primarily lhe [realmenl of calleer) will require
large qllantities of highly pure monoclonal antibodies. which can be
conservatively cstimJK'd Jt 50 kilogramslyCJr rOf CJch thcrapeutic
MAb. Thc c.\ccssivc costs of producing SlI1licicm quantities of MAbs
,,"d the small y,,:lds from convemional technology arc iml'011"nt
11lctorl\ in making rcscm"Ch Dod development of cost effective large
scalc MAl> prodoction csscntial (Stoll cl al. 1996; Zola. 2000; Mel
and YumL 200.tl.
